Your browser doesn't support javascript.
loading
Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing?
Merkel, Drorit; Soffer, Shelly; Novikov, Iliya; Avigdor, Abraham; Amariglio, Ninette; Nagler, Arnon; Trakhtenbrot, Luba.
Afiliación
  • Merkel D; a Division of Hematology , Chaim Sheba Medical Center, Tel Hashomer , Ramat Gan , Israel.
  • Soffer S; b Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.
  • Novikov I; b Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.
  • Avigdor A; c Biostatistical Unit , Gertner Institute of Epidemiology and Health Policy Research , Ramat Gan , Israel.
  • Amariglio N; a Division of Hematology , Chaim Sheba Medical Center, Tel Hashomer , Ramat Gan , Israel.
  • Nagler A; b Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.
  • Trakhtenbrot L; d Hematology Laboratory , Cancer Research Center, Sheba Medical Center , Ramat Gan , Israel.
Leuk Lymphoma ; 60(3): 764-771, 2019 03.
Article en En | MEDLINE | ID: mdl-30187812

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Hibridación Fluorescente in Situ / Citogenética Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Hibridación Fluorescente in Situ / Citogenética Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Israel